December 8, 2025Blood

Short-term erythrocytapheresis is associated with resolution of vertebral osteonecrosis in children with sickle cell disease

View Full Paper

Ask AI

Bookmark

Short-term erythrocytapheresis led to improvement in bone health and renal function in pediatric sickle cell disease patients, indicating potential treatment effectiveness.
Improvements in hemoglobin A and reductions in hemoglobin S levels were observed, with significant statistical significance at p<0.05, underscoring treatment impact.
Retrospective analysis utilized MRI and demographic data to explore treatment outcomes and included a cohort of 171 children with sickle cell disease over two years.
These findings support non-surgical treatment options for addressing vertebral osteonecrosis while emphasizing the importance of further prospective studies.

Authors

SBSani BukariFresno City College FLFred H. LaninghamChildren's Healthcare of Atlanta

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational analysis shows improvement in bone health and renal function in pediatric sickle cell disease, suggesting erythrocytapheresis may enhance treatment outcomes.

Cite This Study

Bukari et al. (2025) studied this question.

synapsesocial.com/papers/69362f3d4fa91c937236d489 https://doi.org/10.1182/blood-2025-3143

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis shows improvement in bone health and renal function in pediatric sickle cell disease, suggesting erythrocytapheresis may enhance treatment outcomes.

Short-term erythrocytapheresis is associated with resolution of vertebral osteonecrosis in children with sickle cell disease

Key Points

Discussion

Implication

Cite This Study

Short-term erythrocytapheresis is associated with resolution of vertebral osteonecrosis in children with sickle cell disease

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider